Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;11(3):186-91.
doi: 10.1016/j.jcm.2012.05.009.

Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report

Jorge H Villafañe  1 , Guillermo B Silva, Alessandro Chiarotto, Orazio L F Ragusa
Affiliations

Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report

Jorge H Villafañe et al. J Chiropr Med. 2012 Sep.

Abstract

Objective: The purpose of this study is to report a case in which combinatory therapy of botulinum toxin type A (BoNT-A) and neurodynamic mobilization (NM) was used as treatment for a patient with severe upper limb spasticity and pain after stroke.

Clinical features: A 76-year-old male patient had spastic muscles in the upper limb 10 months after an ischemic stroke.

Intervention and outcome: The patient underwent combined treatment with BoNT-A and NM of the upper limb in 6 monthly applications. Evaluation was performed pretreatment, 3 months after the first injection, 3 months after the second injection, and at a follow-up session 9 months after starting the treatment. The following outcomes were measured: pain by using a numeric rating scale, spasticity by the Modified Ashworth Scale for Grading Spasticity, acceptance and emotional reaction to the treatment by the Hospital Anxiety and Depression Scale, and functionality by ranges of motion. The patient improved in all outcomes after treatment, and results were maintained during the follow-up sessions.

Conclusion: The combined NM and BoNT-A treatment appeared to decrease pain and improve joint ranges of motion during treatment for this patient. The patient showed decreased anxiety and depression during and after the treatment.

Keywords: Botulinum toxin type A; Muscle spasticity; Physiotherapy; Stroke.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Applied combinatory treatment. A, Physician applying botulinum toxin. B, Static upper-limb orthosis. C, Neurodynamic mobilization of the median nerve.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lim J.Y., Koh J.H., Paik N.J. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke. 2008;39(1):126–131. - PubMed
    1. Yelnik A.P., Colle F.M., Bonan I.V., Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007;78(8):845–848. - PMC - PubMed
    1. Bhakta B.B., Cozens J.A., Bamford J.M., Chamberlain M.A. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry. 1996;61(1):30–35. - PMC - PubMed
    1. Brashear A., Gordon M.F., Elovic E., Kassicieh V.D., Marciniak C., Do M. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347(6):395–400. - PubMed
    1. Kaji R., Osako Y., Suyama K., Maeda T., Uechi Y., Iwasaki M. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol. 2010;257(8):1330–1337. - PMC - PubMed